IMPACT-AD Informational Webinar Announcement
The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) is a novel multidisciplinary Alzheimer’s Disease and Related Dementias clinical trial training program (www.impact-ad.org). The program is funded by the National Institute on Aging and the Alzheimer’s Association. We are excited to announce that the 2022 annual course will take place September 11-16 in La Jolla, CA.
In preparation for this year’s application cycle, we are hosting an IMPACT-AD Informational webinar. The webinar will be a chance for those interested in the course to learn more about this unique training program and to have questions answered by the course co-directors, Drs. Joshua Grill and Rema Raman.
A stated goal of the IMPACT-AD Course is to diversify the nation’s ADRD trialists. As such, we seek applicants from a broad range of geographic, demographic, and professional backgrounds. Please forward this email to any person or organization that you believe may benefit from this course.
This event will be free to register. Anyone interested in the IMPACT-AD course is encouraged to attend. Participation in this webinar is optional and is not required for the submission of an application.
The course will take place in San Diego, CA and will cover a wide range of topics in Alzheimer’s Research and Clinical Trial Design.
Course dates are as follows:
Professionals Track: September 11-14, 2022
Fellowship Track: September 11-16, 2022
After completing this course, Professionals Track attendees should be able to:
After completing this course, Fellowship Track attendees should be able to:
CME credits will be offered through the USC Office of Continuing Medical Education.
The application portal for 2022 has not yet opened. Please check back soon for updates.
Frequently Asked Questions
The IMPACT-AD course is offered once per year.
IMPACT-AD is funded in-part by the National Institutes of Health and is currently offered only to U.S.–based researchers. U.S. citizenship is not required.
Some participants in the professional track may be eligible to apply to a future iteration of IMPACT-AD in the fellowship. In general, however, we recommend only taking the course once.
IMPACT-AD is funded by the National Institutes of Health and the Alzheimer’s Association. Limited positions are available for trainees. The cost of the course and travel expenses are covered by IMPACT-AD for all accepted trainees.
All IMPACT-AD alumni are immediately eligible to join the IMPACT-AD alumni network, which provides exclusive access to the private IMPACT-AD LinkedIn page, IMPACT-AD journal club, as well as the course mailing lists. The course leadership is committed to providing additional opportunities for in–person and virtual networking opportunities.
We suggest that you look for a mentor to provide a strong letter of recommendation and to speak to several important aspects:
- your abilities as an ADRD trialist,
- your potential in the field moving forward, and
- the opportunities available to you in ADRD trials.
When appropriate, letters should confirm your availability commit the time needed to attend the course. Co-letter writers are permitted.
Are there restrictions on what type of trial can be submitted for an IMPACT-AD Fellowship track application?
Applicants should submit an ADRD trial synopsis. Interventional studies (compared to observational studies) have been consistently better received by the IMPACT-AD review committee.
The only requirements are current US residence, strong interest in ADRD trials, and a desire to learn.
For the Fellowship track, applicants should be early-stage faculty or fellowship stage. Graduate trainees have also previously been accepted. For the Professionals track, you can be in any stage of your career, so long as you demonstrate a clear commitment to ADRD clinical trials.
How should applicants decide whether they should apply to the Fellowship track or the Professionals track?
Investigators who have a specific interest in trial protocol development and serving as trial principal investigators are appropriate for the Fellowship track. Clinical trial team members from a variety of roles (clinicians, coordinators, psychometricians, regulatory specialists, etc.) who demonstrate commitment to working in the field and are eager to increase their knowledge and understanding of ADRD trials are appropriate for the Professionals track.
All IMPACT-AD protocol synopses are expected to be original work written by the applicant. Protocol synopsis written by an applicant’s mentor will not fare as well as an original trial proposal. Similarities to other ADRD clinical trials is acceptable so long as the proposed trial is novel in some form.
For the Fellowship track, we request that your protocol has the opportunity to change if you participate in the course. One of the main missions of the Fellowship track is to provide mentoring on the development of the submitted protocol.
Yes, “Pilot” studies are perfectly acceptable using the protocol template for the Fellowship track application.
Considering the role of sponsor is good for anyone developing a trial. This could include considering independent needs, as well as where the supply of the intervention will come from.
Yes, IMPACT-AD is open to industry employees.
Yes, IMPACT-AD is open junior, mid and senior level investigators.